Sentinel Lymph Node Biopsy in Cutaneous Melanoma, a Clinical Point of View
D Brănişteanu, Mihai Cozmin, Elena Porumb‐Andrese, Daniel Brănişteanu, Mihaela Paula Toader, Diana Gabriela Iosep, Diana Sinigur, Cătălina Ioana Brănişteanu, George Brănişteanu, Vlad Porumb, Alin Constantin Pînzariu, Sorin Liviu Băilă, Alin Codruț Nicolescu
Abstract
Sentinel lymph node biopsy (SLNB) is a surgical procedure that has been used in patients with cutaneous melanoma for nearly 30 years. It is used for both staging and regional disease control with minimum morbidity, as proven by numerous worldwide prospective studies. It has been incorporated in the recommendations of national and professional guidelines. In this article, we provide a summary of the general information on SLNB in the clinical guidelines for the management of cutaneous malignant melanoma (American Association of Dermatology, European Society of Medical Oncology, National Comprehensive Cancer Network, and Cancer Council Australia) and review the most relevant literature to provide an update on the existing recommendations for SLNB.